GRF6021

BIOLOGICAL2 trials

Sponsors

Alkahest, Inc.

Conditions

Parkinson DiseasePostoperative Recovery

Phase 2

A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment

CompletedNCT03713957

Alkahest, Inc.Parkinson Disease

Start: 2018-11-12End: 2020-07-20Updated: 2022-05-09

A Study to Evaluate the Effect of GRF6021 on Postoperative Recovery Following Primary Hip or Knee Arthroplasty

CompletedNCT03981419

Alkahest, Inc.Postoperative Recovery

Start: 2019-07-12End: 2021-03-04Updated: 2024-03-13

Related Papers

Infusion of young donor plasma components in older patients modifies the immune and inflammatory response to surgical tissue injury: a randomized clinical trial.

2025-02-14